Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-30 | New | Yet to Sell | $0 | Debt Only | 06b | SEC link |
| 2025-02-03 | New | $750,000 | $750,000 | Equity Only | 06b | SEC link |
| 2024-08-05 | Amended | $8,788,151 | $8,788,151 | Debt Only | 06b | SEC link |
| 2023-11-17 | New | Yet to Sell | $0 | Debt Only | 06b | SEC link |
| 2023-03-23 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2022-07-12 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2021-01-19 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2020-02-18 | New | Yet to Sell | $0 | Debt Only | 06b | SEC link |
| 2019-09-10 | New | $420,012 | $420,012 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Alan Blake | Director, Executive |
| Douglas Bryant | Director |
| John Butler | Director |
| Sanjay Chandra | Director |
| Richard Crockett | Director |
| William Cunningham | Director |
| Walter Narajowski | Director |
| David Shockley | Director |
| H. David Shockley | Director |
| Jeffrey Stukuls | Executive |